tirzepatide effetti collaterali – Endocrinoluigi Tirzepatide: cos'è, effetti collaterali e
Description
doi: 10.3945/ajcn.2009.28095
Any suspected adverse reactions should be reported through the MHRA Yellow Card Scheme
Clinical trials show tirzepatide generally leads to greater average weight loss than semaglutide
GLP-1 receptor agonists commonly cause nausea, vomiting, and diarrhoea, particularly during the initial weeks of treatment or following dose escalation
reduced muscle mass can therefore decrease basal heat production
